Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Borderline or Intermediate Heart Risk: What to Do Next

Borderline or Intermediate Heart Risk: What to Do Next

A borderline or intermediate result means your estimated 10-year risk falls in the range where the next step is not automatic. You are not low enough to set the question aside, and not high enough for the answer to be obvious.

That is the range where extra information is meant to help. The usual sequence is to check for risk enhancers, consider a coronary calcium score if the picture is still unclear, and then decide together with your clinician.

Key takeaways

  • Borderline means a 10-year risk of 3% to under 5%, and intermediate means 5% to under 10%.
  • Risk enhancers such as early family history, high Lp(a) or high ApoB push real risk above the calculated figure.
  • A calcium score is the best-studied tiebreaker when the decision is still uncertain.
  • A score of zero usually supports waiting, with exceptions for diabetes, smoking and strong family history.
  • The final choice is a shared one, and "lifestyle first, then recheck" is a legitimate option.

What the two bands mean

The 2026 ACC/AHA guideline sorts 10-year risk from the PREVENT calculator into four bands: low under 3%, borderline 3% to under 5%, intermediate 5% to under 10%, and high at 10% or more.1

These numbers look small because PREVENT gives lower estimates than the calculator it replaced. Our guide to the PREVENT risk calculator explains the percentages. This article is about what to do once you have one.

Step 1: Check the inputs and look at the long view

Before acting on a middle-band result, confirm that the blood pressure used was a typical reading for you, that the cholesterol values were recent, and that smoking, diabetes and medications were entered correctly.

Then look at your 30-year estimate if you were given one. A younger adult with a borderline 10-year number can have a much higher long-term risk.

Step 2: Go through the risk enhancers

Risk enhancers are findings the calculator does not take in, and that make your true risk higher than your percentage. The best-known list comes from the 2018 US cholesterol guideline. Some you can answer from memory. Others need a blood test.

Risk enhancerHow you find out
Heart disease in a father or brother before 55, or a mother or sister before 65Family history
Chronic kidney disease, metabolic syndrome, or an inflammatory condition such as rheumatoid arthritis or psoriasisMedical history
Preeclampsia, or menopause before age 40Medical history
South Asian ancestryFamily background
LDL cholesterol persistently 160 mg/dL or higher, or triglycerides persistently 175 mg/dL or higherStandard lipid panel
ApoB 130 mg/dL or higher, Lp(a) 50 mg/dL (125 nmol/L) or higher, or hs-CRP 2.0 mg/L or higherAdditional blood tests

In that guideline, the presence of risk enhancers in a person at intermediate risk favors starting statin therapy.2

Note the last row. Three of the enhancers cannot be known unless someone orders the test. Lp(a) is the one most often missed.

One caution: this list was written for the older risk calculator and its higher bands. The idea carries over, but your clinician will apply it with the current guideline in mind.

Step 3: Consider a calcium score as the tiebreaker

If the enhancers do not settle it, a coronary artery calcium (CAC) scan can. It shows whether calcified plaque is already present in the heart arteries.

The evidence for using it this way is reasonably strong. In a US study of 1,330 adults classed as intermediate risk by an older score, researchers compared six extra markers, and coronary calcium improved risk prediction more than any of the others.3

The same study found that family history and hs-CRP also predicted events independently, while carotid wall thickness did not.

How the result is used:

  • Zero. Under the 2026 guideline, a score of zero supports deferring medication and rescanning in three to seven years, unless you have diabetes, smoke, have familial hypercholesterolemia or have a strong family history.1
  • 1 to 99. In the 2018 guideline this favored statin therapy, especially from age 55.
  • 100 or more, or at or above the 75th percentile for your age and sex. This favored statin therapy more firmly.

A zero is common in this group. In a large US cohort, 44% of the adults who qualified for a statin under the guideline of the time had a calcium score of zero, and their rate of cardiovascular events was about 4 per 1,000 people per year.4

For what each score range means, see our guide to the coronary calcium score.

An honest caveat

Extra testing refines an estimate. It has not been proven to save lives. The US Preventive Services Task Force concluded in 2018 that the evidence was insufficient to assess the balance of benefits and harms of adding a calcium score or hs-CRP to traditional risk assessment in adults without symptoms.5

A CAC scan also involves a small dose of radiation, and it cannot see plaque that has not calcified. It is a tool for a decision that is truly uncertain.

Step 4: Decide together

The 2018 guideline describes a clinician-patient risk discussion that covers your major risk factors, any risk enhancers, the potential benefits of lifestyle changes and of statin therapy, the potential for side effects, cost, and your own preferences.2

In practice there are three reasonable outcomes:

  • Work on lifestyle and recheck your numbers at an agreed time.
  • Gather more information first, such as the blood tests above or a calcium score.
  • Start a medication, usually a statin, alongside lifestyle changes.

Do not start, stop or change a medication without your prescriber.

How a Cardio Res-Q assessment maps onto these steps

The Comprehensive Assessment ($775) covers the blood-test enhancers: ApoB, Lp(a) and hs-CRP, along with homocysteine, insulin, glucose and A1c, the Cleveland Heart cardiac panel and Dr. Varano's clinical evaluation. The Enhanced Assessment ($999) adds a coronary calcium score and a CIMT ultrasound.

Two things to know. The calcium scan is done at an outside imaging facility on your provider's order, as a separate self-pay study that typically costs $100 to $200. And CIMT has a weaker evidence base than calcium scoring: US guidance does not recommend it as a routine test for predicting a first event.6

We are glad to share results with your own doctor. To choose between the two options, read Comprehensive vs. Enhanced, or book from the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Is a 6% 10-year risk high?

It is intermediate on the current scale. It means that out of 100 people with numbers like yours, about 6 would be expected to have a cardiovascular event over ten years.

Do I need a statin if my risk is intermediate?

Not automatically. It depends on your risk enhancers, any calcium score, your LDL cholesterol and your preferences. Decide with your clinician.

If my calcium score is zero, can I skip medication?

Often a zero supports waiting and rescanning in a few years. The main exceptions are diabetes, smoking, familial hypercholesterolemia and a strong family history, where a zero is less reassuring.

Should everyone with borderline risk get a calcium scan?

No. If you have no risk enhancers and would not want medication either way, a scan is unlikely to change anything. It is most useful when you and your clinician are undecided and the result would tip the decision.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Blumenthal RS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2026. PMID 41824552 · doi:10.1161/CIR.0000000000001423↩
  2. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
  3. Yeboah J, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012. PMID 22910756 · doi:10.1001/jama.2012.9624↩
  4. Nasir K, et al. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2015. PMID 26449135 · doi:10.1016/j.jacc.2015.07.066↩
  5. US Preventive Services Task Force. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA 2018. PMID 29998297 · doi:10.1001/jama.2018.8359↩
  6. Goff DC Jr, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014. PMID 24239921 · doi:10.1016/j.jacc.2013.11.005↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify